Plasma Factors that Determine Endothelial Cell Lipid Toxicity in Vitro Correctly Identify Women with Preeclampsia in Early and Late Pregnancy

References

• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Robertson W B, Brosens I, Dixon G. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967; 93: 581–92
   PubMedGoogle Scholar
• Spargo B H, Lichtig C, Luger A M, Lindheimer M D, Katz A I. The renal lesion in preeclampsia. Hypertension in Pregnancy, M D Lindheimer, A I Katz, F P Zuspan. Wiley & Sons;, New York 1976; 129–37
   Google Scholar
• Dadak C, Ulrich W, Sinzinger H. Morphological changes in the umbilical arteries of babies born to pre‐eclamptic mothers: and ultrastructural study. Placenta 1984; 5: 419–26
   PubMed Web of Science ®Google Scholar
• Brown M A, Zammit V C, Lowe S A. Capillary permeability and extracellular fluid volumes in pregnancy‐induced hypertension. Clin Sci 1989; 77: 599–604
   PubMed Web of Science ®Google Scholar
• McCarthy A L, Woolfson R G, Raju S K, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168: 1323–30
   PubMed Web of Science ®Google Scholar
• Roberts J M, Redman C W. Pre‐eclampsia: more than pregnancy‐induced hypertension. Lancet 1993; 341: 1447–51
   PubMed Web of Science ®Google Scholar
• Rodgers G M, Taylor R N, Roberts J M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–14
   PubMed Web of Science ®Google Scholar
• Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M, Nakano H. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet Gynecol 1992; 80: 229–33
   PubMed Web of Science ®Google Scholar
• Lorentzen B, Endresen M J, Hovig T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thrombosis Res 1991; 63: 363–72
   PubMed Web of Science ®Google Scholar
• Potter J M, Nestel P J. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979; 130: 165–70
   Web of Science ®Google Scholar
• Kaaja R, Tikkanen M J, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85: 353–6
   PubMed Web of Science ®Google Scholar
• Endresen M J, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440–7
   PubMed Web of Science ®Google Scholar
• Arbogast B W, Lee G M, Raymond T L. In vitro injury of porcine aortic endothelial cells by very low density lipoproteins from diabetic rat serum. Diabetes 1982; 31: 593–9
   PubMed Web of Science ®Google Scholar
• Arbogast B, Berry D L, Newell C L. Injury of arterial endothelial cells in diabetic, sucrose‐fed and aged rats. Atherosclerosis 1984; 51: 31–45
   PubMed Web of Science ®Google Scholar
• Arbogast B W, Gill L R, Schwertner H A. A new protective factor in coronary artery disease: very low density lipoprotein toxicity preventing activity. Atherosclerosis, 1985, 57: 75–86
   Google Scholar
• Arbogast B W. Purification and identification of very low density lipoprotein toxicity preventing activity. Atherosclerosis 1988; 73: 259–67
   PubMed Web of Science ®Google Scholar
• Basu S P, Rao S N, Hartsuck J A. Influence of fatty acids and time of focusing on the isoelectric focusing of human plasma albumin. Biochim Biophys Acta 1978; 533: 66–73
   PubMed Web of Science ®Google Scholar
• Arbogast L Y, Neumann J K, Kostrzewa R M, Arbogast B W. Decreased VLDL toxicity preventing activity in response to a reverse mirror drawing stressor. SAAS Bull Biochem Biotech 1990; 3: 80–4
   Google Scholar
• Arbogast B W, Leeper S C, Merrick R D, Olive K E, Taylor R N. Which plasma factors bring about disturbance of endothelial function in pre‐eclampsia?. Lancet 1994; 343: 340–1
   PubMed Web of Science ®Google Scholar
• Allain C A, Poon L S, Chan C S G, Richmond W, Fu P C. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–5
   PubMed Web of Science ®Google Scholar
• Lopes‐Virella M F, Stone P, Ellis S, Colwell J A. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882–6
   PubMed Web of Science ®Google Scholar
• Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476–82
   PubMed Web of Science ®Google Scholar
• Doumas B T, Biggs H G. Determination of serum albumin. Standard Methods of Clinical Chemistry, G R Cooper. Academic Press, New York 1972; v. 7: 175–88
   Google Scholar
• Arbogast B W, Neumann J K, Kostrzewa R M, Arbogast L Y, Leeper S C. Transient loss of serum protective activity following short term stress: a possible biochemical link between stress and atherosclerosis. J Psychosomatic Res 1994; 38: 871–84
   PubMed Web of Science ®Google Scholar
• Winter A, Karlsson C. Preparative electrofocusing in density gradients. LKB Appl Note 1976; 219: 1–15
   Google Scholar
• Hintze J L. Number cruncher statistical system. NCSS, Kaysville, UT 1991; 269, Version 5.03 9/91
   Google Scholar
• Johnson R, Wichem D. Applied Multivariate Statistical Methods2nd ed. Prentice Hall, New York 1988
   Google Scholar
• Chan S ‐Y, Pollard M. In vitro effects of lipoprotein‐associated cytotoxic factor on rat prostate adenocarcinoma cells. Cancer Res 1978; 38: 2956–61
   PubMed Web of Science ®Google Scholar
• Hessler J R, Morel D W, Lewis L J, Chisolm G M, III. Lipoprotein oxidation and lipoprotein‐induced cytotoxicity. Arteriosclerosis 1983; 3: 215–22
   PubMedGoogle Scholar
• Arbogast B W, Gill L R. Very‐low‐density lipoprotein (VLDL) toxicity reversing activity [abstract]. Fed Proc 1984; 43: 714
   Google Scholar
• Gianturco S H, Bradley W A, Gotto A M, Morrisett J D, Peavy D L. Hypertriglyceri‐demic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest 1982; 70: 168–78
   PubMed Web of Science ®Google Scholar
• Howard B V. Uptake of very low density lipoprotein triglyceride by bovine endothelial cells in culture. J Lipid Res 1977; 18: 561–71
   PubMed Web of Science ®Google Scholar
• Simionescu N. Prelesional changes of arterial endothelium in hyperlipoproteinemic atherogenesis. Endothelial Cell Biology in Health and Disease, N Simionescu, M Simionescu. Plenum Press, New York 1988; 385–429
   Google Scholar
• Gafvels M E, Caird M, Britt D, Jackson C L, Patterson D, Strauss J F. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter‐p23. Somat Cell Mol Genet 1993; 19: 557–69
   PubMedGoogle Scholar
• Lorentzen B, Drevon C A, Endresen M J, Henriksen T. Fatty acid pattern of estenfied and free fatty acids in sera of women with normal and pre‐eclamptic pregnancy. Br J Obstet Gynaecol 1995; 102: 530–7
   PubMedGoogle Scholar
• Endresen M J, Tosti E, Lorentzen B, Henriksen T. Sera of preeclamptic women are not cytotoxic to endothelial cells in culture. Am J Obstet Gynecol 1995; 172: 196–201
   PubMed Web of Science ®Google Scholar
• Shanklin D R, Sibai B M. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol 1990; 163: 943–53
   PubMed Web of Science ®Google Scholar